We advise private Life Sciences companies on finding financial investors and motivated corporate partners. We work with our strategic clients to identify outstanding companies bringing new technologies to market. Our work provides invaluable insights on the market and in particular what makes a transaction successful.Industrial technology has been at the heart of progress for hundreds of years. Whether it’s Quantum Cascade Laser technology, Robotics, Industrial Automation, Dynamic Interferometry, Force / Pressure Sensing, Micro Dispensing or Digital Acoustic Sensing, and many other technologies, EC M&A has secured outstanding outcomes for buyers seeking specific applications, or owners looking for strategic partners or an outright sale.EC M&A is a longstanding, trusted M&A adviser specialising in industrial and life science technologies. We assist global corporates, prominent mid-sized companies, leading private equity firms and some of the most innovative niche companies in our specialised sectors by providing unbiased advice in situations that are pivotal in the corporate life cycle.Manufacturer of custom bioprocessing and pharmaceutical equipment designed to support complex life-science manufacturing and laboratory workflowsWe help you grow through acquisitions or mergers. Leveraging our network to connect you with investment partners to provide for example, growth capital, market guidance, commercial partnership, and strategic insights. We help you realign your business or portfolio of businesses to better suit your corporate objectives.For over 30 years EC M&A has advised firms across US, Europe and Asia on mergers, acquisitions and divestitures. Most corporate events have life changing consequences for those involved. We are proud of an enviable reputation for achieving and very often exceeding our client’s objectives.Buyside M&A is unpredictable and difficult. Having originally built our business providing buyside services to some of the largest multi-nationals we have honed our skills and processes to provide a unique tailored buyside offering. 90% of the companies we buy for our clients are non-auction bilateral transactions; enabling our clients to acquire high quality assets at reasonable prices.Over 70% of our transactions involve the seller in one country and the buyer in another. Having worked for multi-nationals since 1992, we have an unrivalled global network of strategic buyers. By having our own people in three continents we shrink the globe for our clients seeking buyers or targets abroad.Divestitures have their own complications. We have completed over 50 divestitures in the last 20 years providing us with the experience to ensure yours is completed smoothly.Strategic funding solutions take shape in many forms. By leveraging our market knowledge, our network of both strategic investors, their venture arms, Private Equity, and Family office investors, we can access appropriate funding for most client requirements. We work with you to assess the most suitable development of your capital and debt structure, taking into consideration your needs now and in the future, and formulate a customized approach to achieve the best possible outcome for our clients and support them in their strategic goals.